References
- 1. BALAHURA AM, GUŢĂ A, MIHALCEA V, WEISS E, DOROBANŢU M, BARTOŞ D, et al. Pulmonary thromboembolism in an emergency hospital: Are our patients different? Rom J Intern Med. 2017 Jun 27. pii: /j/rjim.ahead-of-print/rjim-2017-0026/rjim-2017-0026.xml.
- 2. STEIN PD, MATTA F, HUGHES PG, HOURMOUZIS ZN, HOURMOUZIS NP, WHITE RM, et al. Home Treatment of Pulmonary Embolism in the Era of Novel Oral Anticoagulants. Am J Med. 2016; 129(9):974-7.
- 3. COHEN AT, GITT AK, BAUERSACHS R, FRONK EM, LAEIS P, MISMETTI P, et al. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thromb Haemost. 2017; 117(7):1326-37.
- 4. AGNELLI G, BULLER HR, COHEN A, CURTO M, GALLUS AS, JOHNSON M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013; 369(9):799-808.
- 5. HOKUSAI-VTE INVESTIGATORS, BÜLLER HR, DÉCOUSUS H, GROSSO MA, MERCURI M, MIDDELDORP S, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013; 369(15):1406-15.
- 6. EINSTEIN INVESTIGATORS, BAUERSACHS R, BERKOWITZ SD, BRENNER B, BULLER HR, DECOUSUS H, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010; 363(26):2499-510.
- 7. EINSTEIN–PE INVESTIGATORS, BÜLLER HR, PRINS MH, LENSIN AW, DECOUSUS H, JACOBSON BF, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012; 366(14):1287-97.
- 8. SCHULMAN S, KEARON C, KAKKAR AK, MISMETTI P, SCHELLONG S, ERIKSSON H, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009; 361(24):2342-52.